Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies

SIMPLE SUMMARY: Epidermal growth factor receptor (EGFR) mutations occur in a significant number of lung cancer patients. Treatment outcomes in this subset of patients has greatly improved over the last decade after the introduction of EGFR tyrosine kinase inhibitors (TKIs), which demonstrated high e...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaddour, Karam, Jonna, Sushma, Deneka, Alexander, Patel, Jyoti D., Abazeed, Mohamed E., Golemis, Erica, Borghaei, Hossein, Boumber, Yanis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267708/
https://www.ncbi.nlm.nih.gov/pubmed/34202748
http://dx.doi.org/10.3390/cancers13133164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267708/
https://www.ncbi.nlm.nih.gov/pubmed/34202748
http://dx.doi.org/10.3390/cancers13133164

Ejemplares similares